beta
Trial Radar AI
I can help you find nearby clinical trials and understand health conditions and treatments.
124 Results
Top 50 Showing
 
Status (Default)
Not yet Recruiting, Recruiting, Active, Not Recruiting
×
 
Intervention
GLP-1, GLP1 receptor agonist
×
 
Type
Drug
×
 
Study Title
Status
Impact GLP-1 Agonists Following Bariatric NCT06132477
Recruiting
GLP-1 RA on Liver OMICS in MASLD NCT06982378
Not yet recruiting
Impact of GLP-1 Receptor Agonists on Patients With IPMN (IPMN-GLP1RA) NCT07014709
Not yet recruiting
Pelvic Floor Disorder Symptoms in Women Seeking Weight Loss Therapy NCT07175805
Not yet recruiting
Bone Metabolism in 12-21 Year Olds Undergoing GLP-1 Receptor Agonist Therapy NCT06903923
Recruiting
Evaluating the Impact of GLP-1 Receptor Agonists With Total Neoadjuvant Therapy in Rectal Cancer NCT07314528
Not yet recruiting
GLP1 Analogues and the Risk of Osteoarthritis NCT07360457
Not yet recruiting
People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists NCT07207148
Recruiting
PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes (PRECIDENTD) NCT05390892
Recruiting
Combination Therapy for Alcohol Use Disorder NCT07249554
Not yet recruiting
Behavioral Therapy and GLP-1 Analogue Effects on Binge Eating, Weight, and Coping in Obesity (BETTER-GLP1) NCT07042672
Recruiting
Beta Cell Function in Type 2 Diabetes: Differential Effects of SGLT2 Inhibitors and GLIP-Receptor Agonists NCT07325435
Active, not recruiting
Association of Gene Polymorphism With Susceptibility to T2DM and the Therapeutic Responses to Exenatide in Chinese Patients With T2DM NCT06256419
Recruiting
Improving Cardiovascular Disease Diagnosis and Treatment in Kazakhstan Using Metabolic Correction With GLP-1 Drugs (ICDDTKZ26) NCT07303556
Active, not recruiting
The Impact of GLP Medication on Colonoscopy Bowel Preparation Quality NCT07127354
Recruiting
Investigating the Impact of GLP-1 RA Therapy on Osteosarcopenia in Older Female Adults With Diabetes (GLOW) NCT07428746
Not yet recruiting
Comparison of Body Composition Changes With Weight Loss Interventions (REFORM) NCT07115069
Recruiting
Cardiovascular and Endothelial Markers During OGTT Before and at Six and Twelve Months Post-treatment in Women With PCOS NCT06889454
Recruiting
Gastric Emptying With Metoclopramide in GLP-1 Agonist Patients Undergoing Elective Surgery (GEM-GLP1RA) NCT07100691
Not yet recruiting
Study of Once-Daily Oral RGT001-075 Compared With Placebo in Adults With Obesity or Are Overweight With Weight-Related Health Conditions (COMO-1) NCT06867718
Active, not recruiting
Effects of Glucagon-like Peptide-1 (GLP-1) Agonist in Neuro-reproductive Function in Obese Adolescent Females With Polycystic Ovary Syndrome (PCOS) NCT07169136
Recruiting
Menopausal Hormone Therapy, GLP-1 Agonists, and Glucose and Energy Homeostasis in Postmenopausal Women With Diabetes (DECLARED-CT) NCT06715514
Recruiting
Comparative Effectiveness of Empagliflozin in the US NCT03363464
Active, not recruiting
A Study to Estimate Early Clinical Efficacy Signals of GLP-1 Agonist Administration in Conjunction With Levonorgestrel Intrauterine Device in Obese Patients With Endometrioid Intraepithelial Neoplasia NCT07107334
Recruiting
Effects of GLP-1RAs on Reproductive Outcomes in PCOS and Obesity NCT06775093
Not yet recruiting
A Trial Within Cohort Feasibility Study Design Comparing Standard of Care Versus Weight Loss (Achieved Through Tirzepatide) for Obesity-related Hypertension in Young Adults (SOLUTION-Pilot) NCT07364175
Recruiting
GLP-1 and Hyperoxia for Organ Protection in Heart Surgery (GLORIOUS) NCT02673931
Active, not recruiting
A Study of a Weight Loss Intervention in People With Endometrial Cancer NCT06751589
Recruiting
Testing the Efficacy, Safety, and PK of 20E in Patients With Obesity Who Are Starting Treatment With the GLP-1 Agonist Semaglutide for Weight Loss. (OBA) NCT07411378
Not yet recruiting
Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Therapy and Exercise Training in People With Obesity NCT07091500
Recruiting
Efficacy and Safety of iGlarLixi Versus Standard of Care in a Real-world Adult China Population With Uncontrolled Type 2 Diabetes on Oral Agents NCT07307235
Not yet recruiting
Pharmacogenetics of the Response to GLP-1 in Mexican-Americans With Prediabetes NCT05119179
Recruiting
A Clinical Trial Evaluating TQF3250 Capsules in Healthy Adult Subjects NCT07327281
Recruiting
DECODE - Haemodynamic Effects Of Semaglutide and Tirzepatide - a Series of Pilot Studies NCT07483801
Not yet recruiting
Alleviating Carbohydrate Counting for Patients with Type-1 Diabetes Using a Closed Loop System with Weekly Subcutaneous Semaglutide (SEMA SMA) NCT06387199
Recruiting
Combination of Biologic and Anti-obesity Therapies in Psoriatic Arthritis (COMBAT-PsA) NCT07443956
Not yet recruiting
Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKD (ADIPO-CKD) NCT07309094
Recruiting
Brain Plasticity and GLP-1 Receptor Agonist Treatment for Obesity (PLASTIC) NCT07021937
Not yet recruiting
A Study to Evaluate DD01 in Overweight/Obese Subjects With MASLD/MASH NCT06410924
Active, not recruiting
Direct Measurement of Microstructure of Ingestive Behaviour After Initiation of GLP-1 Receptor Agonist Treatment at Maximum Dose (DIGRAT) NCT07457424
Active, not recruiting
GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance NCT04731272
Recruiting
Prevention of Progression of Prediabetes, Obesity and CV Risk (Pre-DM) NCT06446531
Recruiting
Safety and Efficacy of NA-931 and Tirzepatide in Adults Who Are Overweight or Obese NCT06732245
Not yet recruiting
GLP-1/GCG Dual Agonist in Type 2 Diabetes With Early Dementia (LIGHT-COG Study) NCT07083154
Recruiting
Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes NCT06706284
Recruiting
Does Semaglutide Improve Depressive Symptoms in Patients With Major Depressive Disorder and Overweight or Obesity (SEMAMOOD) NCT07136714
Recruiting
Role of GLP1 RA Dulaglutide on Severe Intracranial Atherosclerosis (RADIANT) NCT07282041
Recruiting
Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients NCT06774079
Recruiting
Effect of Weekly GLP1 Agonist Treatment in "Double Diabetes" (TOLEDDO) NCT05305794
Recruiting
GLP-1 Receptor Agonist for Reduction of Myocardial Injury After Non-cardiac Surgery (GLUMINS) NCT06324461
Recruiting